Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis

Breyanzi (lisocabtagene maraleucel) - BMS

Kymriah (tisagenlecleucel-T) - Novartis

Isocel (ALEXIS-ISO-1) - Immunocell Therapeutics

Yescarta (axicabtagene ciloleucel) - Gilead

https://www.sciencedirect.com/science/article/abs/pii/S2152265026026145

Hafiz Muhammad Ehsan Arshad MBBS 1; Maryam Maqsood MBBS MD 2; Muhammad Zain Raza MBBS 1; Musab Maqsood MBBS 1; Anas Babar MBBS 1; Omar Abdullah Gill MBBS 1

Sep 1, 2026